tiprankstipranks
Jade Biosciences (JBIO)
NASDAQ:JBIO
US Market
JBIO
Jade Biosciences
RESEARCH TOOLSreports

Jade Biosciences (JBIO) Financial Statements

197 Followers

Jade Biosciences Financial Overview

Jade Biosciences's market cap is currently $763.91M. The company's EPS TTM is $-0.451; its P/E ratio is -3.80; and it has a dividend yield of 14.68%. Jade Biosciences is scheduled to report earnings on March 6, 2026, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -26.00K$ -282.00K$ -96.00K$ -68.00K$ -15.00K
Operating Income$ -113.54M$ -74.60M$ -81.41M$ -53.24M$ -23.02M
EBITDA$ -113.54M$ -69.29M$ -75.37M$ -51.42M$ -22.95M
Net Income$ -127.41M$ -69.63M$ -75.52M$ -51.51M$ -22.96M
Balance Sheet
Cash & Short-Term Investments$ 336.16M$ 78.62M$ 122.44M$ 129.22M$ 167.38M
Total Assets$ 349.78M$ 80.33M$ 127.42M$ 135.30M$ 175.36M
Total Debt$ 724.00K$ 417.00K$ 675.00K$ 1.09M$ 574.00K
Net Debt$ -87.71M$ -33.33M$ -22.82M$ -21.31M$ -53.62M
Total Liabilities$ 17.26M$ 3.90M$ 17.96M$ 8.56M$ 2.94M
Stockholders' Equity$ 332.52M$ 76.43M$ 109.46M$ 126.74M$ 172.42M
Cash Flow
Free Cash Flow$ -94.89M$ -71.20M$ -56.92M$ -39.32M$ -27.58M
Operating Cash Flow$ -94.69M$ -71.20M$ -56.78M$ -39.12M$ -27.40M
Investing Cash Flow$ -247.01M$ 56.03M$ 11.88M$ 6.93M$ -113.43M
Financing Cash Flow$ 360.77M$ 25.43M$ 46.00M$ 396.00K$ 190.46M
Currency in USD

Jade Biosciences Earnings and Revenue History

Income Statement >

Jade Biosciences Debt to Assets

Balance Sheet >

Jade Biosciences Cash Flow

Cash Flow >

Jade Biosciences Forecast EPS vs Actual EPS

Earnings >